MedPath

江苏新海康制药有限公司

Ownership
-
Established
1990-09-18
Employees
-
Market Cap
-
Website
http://www.jsxhkzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

健脾化滞锭

Approval Number
国药准字Z20025446
Approval Date
Jun 30, 2020
NMPA

Cilostazol Tablets

Product Name
西洛他唑片
Approval Number
国药准字H20103401
Approval Date
Jun 30, 2020
NMPA

健脾八珍糕

Approval Number
国药准字Z32020515
Approval Date
Jun 30, 2020
NMPA

Colloidal Bismuth Pectin Capsules

Product Name
胶体果胶铋胶囊
Approval Number
国药准字H20093592
Approval Date
Apr 29, 2019
NMPA

Lacidophilin Granules

Product Name
乳酸菌素颗粒
Approval Number
国药准字H20093584
Approval Date
Apr 29, 2019
NMPA

Hydrotalcite Chewable Tablets

Product Name
铝碳酸镁咀嚼片
Approval Number
国药准字H20093610
Approval Date
Apr 29, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.